DITURI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 899
EU - Europa 155
AS - Asia 70
Totale 1.124
Nazione #
US - Stati Uniti d'America 899
CN - Cina 53
SE - Svezia 51
BE - Belgio 41
IT - Italia 21
DE - Germania 18
GB - Regno Unito 9
FI - Finlandia 7
IN - India 6
JP - Giappone 6
VN - Vietnam 3
FR - Francia 2
AL - Albania 1
DK - Danimarca 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
NL - Olanda 1
PH - Filippine 1
RS - Serbia 1
Totale 1.124
Città #
Fairfield 144
Woodbridge 138
Chandler 114
Seattle 65
Ashburn 61
Houston 60
Cambridge 57
Ann Arbor 56
Wilmington 54
Nyköping 45
Brussels 41
Beijing 20
Nanjing 13
Lawrence 12
Roxbury 12
Bari 10
San Diego 8
Inglewood 7
Redwood City 6
Tokyo 6
Brooklyn 5
Des Moines 5
Jiaxing 5
Dearborn 4
Falls Church 4
Tianjin 4
Dong Ket 3
Jacksonville 3
Boardman 2
Coimbatore 2
Grafing 2
Hebei 2
Jinan 2
London 2
Nanchang 2
Nürnberg 2
Ostuni 2
Princeton 2
Torricella 2
Belgrade 1
Brindisi 1
Budapest 1
Copenhagen 1
Dublin 1
Esslingen am Neckar 1
Groningen 1
Hangzhou 1
Helsinki 1
Kunming 1
Lanzhou 1
Lequile 1
Manila 1
Miami 1
Mumbai 1
Norwalk 1
Paris 1
Phoenix 1
San Francisco 1
San Jose 1
San Mateo 1
Shenyang 1
Tappahannock 1
Tel Aviv 1
Tirana 1
Totale 1.009
Nome #
NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC 120
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts 109
Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma 104
TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives 87
null 86
TGF-β and the tissue microenvironment: Relevance in fibrosis and cancer 86
Dietary ω-3 polyunsaturated fatty acids inhibit tumor growth in transgenic Apcmin/+ mice, correlating with CB1 receptor up-regulation 81
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: A prospective clinical study 78
Precision medicine for hepatocelluar carcinoma using molecular pattern diagnostics: Results from a preclinical pilot study 75
null 74
Transforming growth factor-β promotes morphomechanical effects involved in epithelial to mesenchymal transition in living hepatocellular carcinoma 72
null 70
Valutazione della percezione del rischio biologico in un gruppo di operatori di igiene dentale in formazione e di ruolo 47
Epigenetic upregulation and functional role of the mitochondrial aspartate/glutamate carrier isoform 1 in hepatocellular carcinoma 27
Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332/α3 integrin axis recovery of focal adhesion kinase ubiquitination 25
Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression 17
Totale 1.158
Categoria #
all - tutte 3.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.027


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201995 0 0 0 0 0 3 1 0 1 24 32 34
2019/2020387 41 20 16 43 39 32 38 47 51 24 18 18
2020/2021201 7 20 9 18 11 24 17 20 11 27 13 24
2021/2022111 4 2 2 7 7 14 2 14 10 6 16 27
2022/2023255 28 41 22 29 20 27 4 31 33 3 11 6
2023/202426 6 17 3 0 0 0 0 0 0 0 0 0
Totale 1.158